English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/178568
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


A non-conserved amino acid variant regulates differential signalling between human and mouse CD28

AuthorsPorciello, Nicla; Borroto Revuelta, Aldo ; Alarcón, Balbino ; Tuosto, Loretta
Issue Date2018
PublisherNature Publishing Group
CitationNature Communications 9 (2018)
AbstractCD28 superagonistic antibodies (CD28SAb) can preferentially activate and expand immunosuppressive regulatory T cells (Treg) in mice. However, pre-clinical trials assessing CD28SAbs for the therapy of autoimmune diseases reveal severe systemic inflammatory response syndrome in humans, thereby implying the existence of distinct signalling abilities between human and mouse CD28. Here, we show that a single amino acid variant within the C-terminal proline-rich motif of human and mouse CD28 (P in human vs. A in mouse) regulates CD28-induced NF-κB activation and pro-inflammatory cytokine gene expression. Moreover, this YAPP sequence in humans is crucial for the association of CD28 with the Nck adaptor protein for actin cytoskeleton reorganisation events necessary for CD28 autonomous signalling. This study thus unveils different outcomes between human and mouse CD28 signalling to underscore the importance of species difference when transferring results from preclinical models to the bedside.
Identifiersdoi: 10.1038/s41467-018-03385-8
issn: 2041-1723
Appears in Collections:(CBM) Artículos
Files in This Item:
File Description SizeFormat 
AlarcónB_ANon-ConservedAmino.pdf1,9 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.